Inovalon (INOV) Issues FY19 Earnings Guidance

Share on StockTwits

Inovalon (NASDAQ:INOV) issued an update on its FY19 earnings guidance on Wednesday morning. The company provided EPS guidance of $0.41-0.47 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.43. The company issued revenue guidance of $637-657 million, compared to the consensus revenue estimate of $647.06 million.Inovalon also updated its FY 2018 guidance to $0.27-0.34 EPS.

INOV traded down $0.09 during midday trading on Wednesday, hitting $10.08. The company had a trading volume of 356,478 shares, compared to its average volume of 525,747. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 1.38. The stock has a market capitalization of $1.43 billion, a PE ratio of 43.83, a PEG ratio of 2.38 and a beta of 1.02. Inovalon has a twelve month low of $8.90 and a twelve month high of $16.90.

Several equities research analysts have weighed in on INOV shares. BidaskClub upgraded shares of Inovalon from a hold rating to a buy rating in a research report on Saturday, October 13th. ValuEngine cut shares of Inovalon from a hold rating to a sell rating in a research report on Tuesday, September 4th. Finally, Zacks Investment Research upgraded shares of Inovalon from a hold rating to a strong-buy rating and set a $14.00 price objective for the company in a research report on Tuesday, August 7th. One equities research analyst has rated the stock with a sell rating and four have given a hold rating to the company. The stock has a consensus rating of Hold and an average target price of $11.67.

COPYRIGHT VIOLATION WARNING: This article was originally reported by Week Herald and is the sole property of of Week Herald. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international trademark and copyright law. The legal version of this article can be read at

Inovalon Company Profile

Inovalon Holdings, Inc, a technology company, provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models in the healthcare industry. The company's platform enables the assessment and enhancement of clinical and quality outcomes and financial performance.

Featured Article: Do closed-end mutual funds pay dividends?

Receive News & Ratings for Inovalon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon and related companies with's FREE daily email newsletter.

Leave a Reply